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1. Introduction 
Although glaucoma, known to be the most common cause of irreversible blindness, is 
characterized by progressive loss of retinal ganglion cells, it has long been perceived as a 
disease caused by “increased intra-ocular pressure (IOP)”. Although increased IOP has been 
recently removed from the definition of glaucoma and regarded as a major risk factor and 
glaucoma has been defined as an optical neuropathy, clinical practices are still 
predominantly oriented towards the reduction of IOP (Gupta & Yücel, 2007).  Yet the 
neuroprotective strategies developed are of limited use due to both variety and receptors 
and ion channels and the severity of side effects. Moreover, clinical studies are not sufficient 
(Danesh-Meyer, 2011). Recently, we have many medical therapeutic agents that have 
reduced IOP via different mechanisms. When target IOP defined for particular patients 
cannot be reached using medical therapy, ophthalmologists still have different options. 
Trabeculectomy with or without antimetabolites remains the golden standard for most of 
the primary and secondary glaucomas when medical and laser therapy are insufficient. 
However, some eyes are unresponsive to this therapy as well (Coleman & Brigatti, 2001). In 
a study conducted on 709 eyes of 566 patients, the variability of the efficiency of standard 
trabeculectomy has been reported with the mean follow up of 27.9 months (Mietz et al, 
1999). According to the study, success rates for complete surgical success ranged from 59% 
in the best group with pigmentary dispersion syndrome to 0% in the worst group with 
neovascular glaucoma. Success rates of patients with POAG, pseudoexfoliation, chronic 
angle closure, pigmentary dispersion syndrome, and dysgenetic glaucoma were similar. 
Failure rates ranged from 11% in the best group (pseudoexfoliation) to 80% in the worst 
group (neovascular glaucoma). Failure rates were high in complicated forms of glaucoma, 
such as traumatic (30%), buphthalmos (40%) and uveitic (50%). For repeat trabeculectomies, 
the failure rate was 49% (20 out of 41 eyes). The mean time until failure ranged from 2.7 
months (traumatic) to 15.5 months (pigmentary dispersion syndrome) and was 4.9 months 
for repeat trabeculectomies. 
2. Current strategies for refractory glaucoma 
Neovascular glaucoma (NVG) is reported to be the worst type in terms of failure rates 
(Mietz et al, 1999). Recommendations for treatment of NVG include treatment of the 
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underlying disease, complete panretinal photocoagulation if retinal ischemia is a factor 
(Sivak-Callcott et al, 2001), and anterior retinal cryoablation (ARC), especially in eyes with 
media opacities and as a preliminary procedure for filtering surgery or drainage implant 
surgery (Sandramouli et al, 1993). Recently, intravitreal agents in the treatment of such 
patients have constantly increased in importance. Intravitreal bevacizumab administration 
does not directly cause reduction in IOP, but it provides support to medical and invasive 
treatments to be applied to such patients due to rapid control of anterior segment 
neovascularization and improved symptomatic relief (Ghosh et al, 2010; Kotecha et al, 2011). 
In general terms, with respect to the approaches for cases with refractory glaucoma, there 
are different surgical and laser techniques in the literature. Although the ideal surgical 
procedure is still controversial, currently, trabeculectomy with antimetabolite therapy, 
aqueous shunt implants (Yalvac et al, 2007), and diode laser cyclophotocoagulation (Pokroy 
et al, 2008) are the favored surgical treatment options. The most important cause of failure in 
glaucoma surgery is the fibrocellular scar tissue formation in the infiltration area. To date, 
many drugs have been tried and are being tried, which may control intra-cellular signal 
conduction pathways in order to prevent proliferation of fibroblasts in such areas. Among 
the drugs used for this purpose, the most popular one is, recently, Mitomiycn and 5-FU. 
Side effects of those compounds seriously limit their clinical use (Sleep, 2010). Among all 
side effects, the most important ones include filtrating bleb infections (Mac & Soltau, 2003) 
and endophthalmy (Lehmann et al, 2000), corneal endothelial damage (Mattox, 1995), 
hypotony and rare associated retinal bleeding  (Suzuki et al, 1999).    
Aqueous shunts are useful options in the management of complicated glaucoma, where 
conventional filtration surgery is considered to carry a high risk of failure. The Ahmed 
Glaucoma valve is an accepted device that has integrated mechanisms to sustain a residual 
intraocular pressure in order to avoid postoperative hypotony and related complications 
(Hille et al, 2004). According to a comparative retrospective study reported by Taglia et al, 
success rates – IOP below 15mmHg at 1 year - were 80%  for the Molteno implant, 39% for 
the Krupin Eye Valve with Disc, and 35% for the Ahmed Glaucoma Valve. However, 
Ahmed Glaucoma Valve patients were less likely to experience complications requiring 
reoperations or loss of two or more lines of visual acuity than the others (Taglia et al, 2007). 
In one of the retrospective studies regarding the Ahmed Glaucoma valve, postoperatively, 
15% of 159 eyes were reported to have intraocular pressure equal to or greater than 22 
mmHg. According to that study, the complication rate was 47% and the most common 
complication was obstruction of the tube (11%) (Huang et al, 1999). In a study performed 
specifically on NVG patients, cumulative probabilities of success were 63.2% after one year 
in the Ahmed Glaucoma valve group (Yalvac et al, 2007). In literature, loss of light 
perception in NVG was encountered as 31% and 48% after Baerveldt (Sidoti et al, 1995) and 
Molteno (Mermoud et al, 1993)  tube implantations, respectively. 
Another important focus of interest in the fight against refractory glaucoma is the ciliary body 
and it has wide area practices, since it is generally targeted to reduce formation of aqueous. 
Now, the most commonly recognized method is the diode transscleral cyclophotocoagulation. 
In a new study conducted on 32 refractory eyes, which had the aqueous tube shunt previously 
applied, undergoing diode transscleral cyclophotocoagulation up to 360 degrees, 7.5 mmHg 
and 7.9 mmHg IOP reductions were found in 1-month and 1-year follow-up, respectively, and 
the complications were reported to be hypotony (n=4), hyphema (n=2), failed corneal 
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transplant (n=1), and loss of light perception (n=5) (Ness et al, 2011). In another study where 
diode laser cyclophotocoagulation was compared with another technique for the ciliary body, 
namely cyclocryotherapy (Tzamalis et al, 2011), it was reported that both methods were 
efficacious and safe and it was concluded that the primary treatment option in refractory 
glaucomas should be diode laser cyclophotocoagulation. 
Aside from diode laser cyclophotocoagulation, the ciliary body has been a focus of interest 
since Sautter’s operation in the early 80’s (Sautter & Demeler, 1984). More recent techniques 
targeting the ciliary body include Contact and Noncontact transscleral Neodynium: Yttrium 
Aluminium Garnet (Nd:YAG) cyclophotocoagulation, and are also useful in refractory 
glaucomas. A long-term follow-up of 500 patients treated with noncontact transscleral 
Nd:YAG cyclophotocoagulation was carried out. Satisfactory intraocular pressure reduction 
was achieved in 62% and 87% of the patients with single and repeated treatment sessions, 
respectively. However, visual loss remained a significant postoperative complication, with 
some degree of reduced vision occurring in 39% of the study population. Patients with 
neovascular glaucoma yielded the greatest rate of visual loss at 46%. Unsatisfactory 
intraocular pressure reduction and reduced vision rates for contact transscleral 
cyclophotocoagulation were reported as 50% and 27%, respectively (Shields & Shields, 
1994). 
A surgical technique on the ciliary body to reduce aqueous formation by partially excising 
the pars plicata was described by Sautter in 1980s. The technique was first applied to and 
published for 6 (5 narrow- angle and 1 primary open-angle glaucoma) aphacic eyes and it 
was referred to as the Suatter operation (Sautter & Demeler, 1976). With this technique, 
60o-150o of the ciliary body was surgically removed. They reduced intraoperative 
complications, such as vitreous loss and vitreous haemorrhages from the ciliary body 
vessels to a minimum by the use of a Fleiringa-ring, a paracentesis and an extensive 
cauterisation of the ciliary body tissue. The postoperative complication of scleral wound 
dehiscence was also reduced by a double scleral wound closure. The same two surgeons 
reported the results of 106 ciliary body excisions in a total of 90 eyes, between 1974 and 
1984 (Sautter & Demeler, 1984). According to the paper, after six months, intraocular 
pressure was 19 mm Hg or less in 60 eyes with no other treatment, although ten eyes 
required a second excision. Another five eyes had intraocular pressures of 19 mm Hg or 
less with medical therapy (one reoperation) and seven had intraocular pressures of 22 mm 
Hg or less without medical therapy (one reoperation). The ciliary body excision failed in 
13 eyes. Four of these had persistent hypotony (intraocular pressures of less than 4 mm 
Hg) and nine had intraocular pressures above 40 mm Hg. Reasons for failure included 
rubeosis iridis (seven eyes), an overlarge excision (three eyes), and expulsive hemorrhage, 
siderosis bulbi, and Lowe's syndrome (one eye each). Postoperative visual acuity was 
unchanged in 45 eyes, somewhat improved in 15, and worse in 21. Although a series was 
also published where a success rate of almost 80% was reported (Demeler, 1986), this 
brutal surgery was quit over the course of time. 
Cyclectomy/Trabeculectomy (C/T), a modified trabeculectomy operation described by 
Engin G in the early 90’s, is particularly suggested for refractory glaucomas. When 
compared with the Sautter operation in which 60o-150o of the pars plicata were excised, the 
filtering effect of the C/T technique is more important than the decrease of aqueous 
formation. That difference also allowed the surgeon to avoid major haemorrhage 
complications, even in cases with neovascular glaucoma. 
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3. Cyclectomy/trabeculectomy procedure (engin operation) 
3.1 Surgical technique 
Unless a special condition is indicated, operations were performed under regional 
anesthesia. Heads of the patients were kept slightly elevated and they were monitorized to 
secure safe and hypotensive surgery. 
Globe fixation was ensured with saturation of superior rectus with 4.0 silk. Limbus based 
flep was brought down on the cornea by fairly peeling the anatomic limbus. 
 
 
Fig. 1. A. A limbus based conjunctival flap was dissected. A half thickness scleral flap 
(4x6mm) was prepared. In order to prevent potential bleeding, the whole deep sclera and 
nearby was cauterized until a mild color change was achieved. This practice also decreases 
flap adhesion. 
 
 
Fig. 1. B. Excision of a deep scleral piece of 2x4mm, posterior to the trabecular projection on 
the limbus grayline was performed. In the C/T operation, deep sclerectomy incision was prepared 
even more posteriorly to visualize the processes of the ciliary body and to carry out a partial excision. 
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Fig. 1. C. A full thickness ciliary body fragment of the same dimensions of 2x4 mm was 
excised between 1 and 3 mm posterior to the clinical limbus.Our experience has it that the iris 
root bleeds more than the ciliary process. The cyclectomy procedure feels like cutting out a piece from 
a sponge.   
 
 
 
Fig. 1. D. The anterior chamber was entered just from the bottom of the cornea by separating 
it from the iridocorneal angle (4mm) with a spatula. Afterwards, the majority of the iris and iris 
root was removed via partial cyclodialysis. Thus, although cyclodialysis and its full range of effects 
are not particularly designated, a limited dialysis takes effect as a side element of the procedure. 
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Fig. 1. E.The trabeculum of 2x3mm was excised with peripheral iridectomy. Thus, a wide 
passage from the anterior chamber to the posterior of the lens was completed.    
 
 
 
 
Fig. 1. F. The scleral flap was closed with 2 or 4 10.0 absorbable sutures.The operation was 
completed with the closing of the conjunctival flap by an 8.0 polyester running suture.  
Neither an extra surgical device, nor antimetabolites were used. We currently regard the use 
of Mitomycine as an unnecessary risk in the C/T technique due to the wide filtration area 
(Figure 2). 
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Fig. 2. Comparison of the filtration areas and probable routes of aqueous humor in standart 
trabeculectomy (A) and C/T operation (B).  
3.2 Early and late results reported for C/T operation 
Early results of the technique were reported on 55 desperate glaucomatous eyes of 52 
patients -25 female and 27 male- with an average age of 52.4 years (in the range of 18-80 
years) (Engin et al, 2007). The eyes with IOP remaining above 30 mmHg despite all medical 
therapies, and at least one glaucoma operation were selected for the operation. The 
etiological  factors were 24 neovascular, 7 pseudophakic, 6 hereditary, 3 malignant, 3 
postkeratoplasty, 3 postuveitic, 3 aphakic, 3 traumatic and 3 primary open angle glaucomas. 
All of the operated eyes were analyzed retrospectively. The IOPs, which varied between 32-
80 (52.49±12.94) mmHg preoperatively, decreased to 5-28 (13.85±4.73) after the operation. 
IOPs were under 20 mmHg in 50 eyes without additional medical hypotensive therapy. A 
topical beta blocker was applied to the other five eyes. In 51 out of 55 eyes, the visual 
acuities increased or remained stable.  
The complications were similar to those seen after trabeculectomy. No zonular damage or 
subluxation of the lens was observed, however, in three cases, the lens touch precipitated 
the cataract formation. No shallow anterior chamber after the operation was observed. The 
filtering bleb was always flat. Transient hyphema (27/55) was the most common 
complication and all of them resolved spontaneously in 2-5 days. The serious retinal 
detachments (2/55) that we observed were limited  to the inferior part of the retina. It 
continued for two weeks, and then regressed spontaneously without any effect on visual 
acuity. Other postoperative complications observed were transient hypotony (8/55), 
anterior chamber inflammation (8/55) and intravitreal hemorrhage (5/55), conjunctival 
wound dehiscence (5/55), and choroidal detachment (6/55). 
Peroperative problems were quite rare. Leaky hemorrhage from the iris base was seen in 11 
patients. More insistent bleedings were observed in five neovascular glaucomas but they 
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were easily controlled by a simple cauterization. Vitreous loss was observed in six patients - 
two of them were aphakic - in which anterior vitreous and hyaloid integrity were broken. A 
vitreous excision was performed in order to prevent a blockage at the filtration site.   
As for the late results, 42 eyes of 40 patients -22 female and 18 male- with an average age of 
50.3 years (in a range of 18-86 years) were included in a retrospective study (Engin et al, 
2004). All were difficult cases with glaucomas of various etiologies and 29 of them had at 
least one previous unsuccessful glaucoma operation. Four of the eyes were so desperate that 
they could represent an indication of enucleation. The etiologies were 21 neovascular, 5 
hereditary, 4 pseudophakic, 3 aphakic, 3 malignant, 3 postkeratoplasty, and 3 postuveitic  
glaucomas. After a follow - up period of 2 to 5 years in 42 eyes, the IOPs which had varied 
between 34-80 mmHg preoperatively decreased after the operation and remained under 20 
mmHg in 39 eyes. Only nine eyes needed topical therapy. In eight out of 42 eyes, the visual  
acuities improved while they remained the same in 32 eyes. The vision decreased in two 
eyes due to the development of secondary cataract. Complaints such as photophobia and 
ocular irritation disappeared in all patients. Complications were similar to those seen both 
after the trabeculectomy and our early results. 
3.3 Results of combined C/T in neovascular glaucoma cases 
Twenty-five eyes out of 23 cases with NVG have been included in this study. All the 
patients had been receiving triple medication consisting of Timolol, Dorzolamide and 
Bimatoprost. The gender distribution of this group was 14 female and 9 male and the 
average age was 62.7 years (in a range of 54-79 years). They were operated on with this 
technique from 1994 to 1999. The follow-up period was 12 months. The preop average IOP 
was 53.76 (38-80) mmHg and preop visions were from “no light perception” to 0.3. The main 
etiology was proliferative diabetic retinopathy. All the patients had been receiving triple 
medication consisting of Timolol, Dorzolamide and Bimatoprost and they were also 
undergoing treatment in our retina department. Written approval was obtained from each 
patient. None of the patients was perioperatively administered any antifibrotics or VEGF 
inhibitors. 
Following all C/T operations undertaken in our clinic between 1994 and 2000, the excised 
specimens were photographed by an ophthalmic pathologist and confirmed as ciliary 
bodies. Postoperative comfort was evaluated with questionnaires regarding complaints, 
such as pain, photophobia and ocular irritation. Data regarding postoperative follow ups 
were analyzed retrospectively. Best corrected visual acuities with Snellen charts, IOPs taken 
by applanation tonometer and complications determined in routine examinations were 
recorded at the end of the first week and after six and 12 months. Cases with IOP between 5 
to 20 mmHg, without additional medical therapy were considered as a complete success in 
terms of IOP lowering, whereas IOP less than 5 mmHg was recorded as hypotony. 
Prostaglandin analogues and/or aqueous suppressants were added to the therapy in eyes 
bearing IOP higher than 21 mmHg or complication. 
At the end of the 1st year, vision preservations and success rates were found to be 92% and 
72%, respectively. Complaints such as photophobia and ocular irritation disappeared in all 
patients. In five out of 25 eyes, the visual acuities increased while remained the same in 18 
eyes. The vision decreased in two eyes (Figure 2A). In 23 out of 25 eyes, the IOPs 
postoperatively decreased and remained under 20 mmHg. Seven out of 25 eyes needed 
medical therapy (Figure 2B).  
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Fig. 2. Vision preservations (A) and success rates (B) S: Same, I: Increased, D: Decreased, 
IOP: Intraocular pressure.  
Transient hyphema was the most frequent complication (40%) and resolved spontaneously 
in 2-5 days. No shallow anterior chamber after the operation was observed despite the 
occurrence of choroidal detachment (8%). The serious retinal detachments that we observed 
(4%) were limited to the inferior part of the retina. No zonular damage and subluxation of 
the lens were observed, however, in one case, lens touch precipitated cataract formation 
(4%). Hypotony was found to be 20% (Table 1). 
In this study, vision preservations and success rates were found to be 92% and 72%, 
respectively, -which were both higher than the 76.4% and 63.2% of the Ahmed valve 
operations in NVG, respectively (Yalvac et al, 2007). Visual acuity reduced in two eyes due 
to cataract formation in the C/T group and this was not a specific complication of the C/T 
operation (Hylton et al, 2003). 
The most common complication seen in the C/T group was hyphema. In a study reporting 
results after Trabeculectomy with MMC combined with direct cauterization of peripheral 
iris in patients with NVG, 20.8% hyphema was reported, in which irrigation of the anterior 
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chamber was required for three eyes (Elgin et al, 2006). We had a rate of 40% but all the 
hyphemas were resolved spontaneously in our series. That rate was also higher than 31% of 
our previous series with various etiologies (Engin et al, 2004; Engin et al, 2007). Consistent 
with the findings with the Ahmed Glaucoma valve in NVG, transient hyphema was the 
most common complication (Yalvac et al, 2007). It was reported between 8 and 20% with 
tube implantation in NVG (Sidoti et al, 1995 ; Mermoud et al, 1993). Hypotony was found to 
be 20% in our series, while the occurrence of these complications was reported both times 
previously as 5.3% with the Ahmed Glaucoma valve in NVG (Yalvac et al, 2007). 
Postoperative hypotony was reported between 8% (Huang et al, 1999) and 13% (Coleman et 
al, 1995) in other Ahmed Glaucoma valve series. Although that rate is higher than those 
previously reported in the literature, it was not a major problem clinically.  
 
Complications Ratios 
Transient hyphema                                             10/25 (%40) 
Transient hypotony                                               5/25 (%20) 
Transient  anterior chamber inflammation               4/25 (%16) 
Transient intravitreal hemorrhage                          2/25 (%8) 
Choroidal detachment                                           2/25 ( %8) 
Serous retinal detachment                                     1/25 (%4) 
Secondary cataract                                               1/25 (%4) 
Mild vitreus loss                                                    1/25 (%4) 
Shallow anterior chamber                   None 
Conjunctival wound dehiscence None 
Corneal insufficiency None 
Table 1. Postoperative complications 
4. Conclusions 
When we compare the C/T procedure with the other known techniques above -as far as IOP 
reducing effect and vision preserving properties are concerned-, the superiority of the C/T 
technique is clearly seen. Clinical trials comparing the C/T technique with standard 
trabeculectomy, however, would be of great importance. On the other hand, the 
complications that we have observed were less frequent, and not worse than, standard 
trabeculectomy in incidence and severity. Since an external device is not used, it not only 
reduces the cost of surgery, but also removes from the surgeon’s agenda the possibility of 
complications arising from such devices. It is particularly remarkable that no endophthalmy 
or bleeding, which may pose a threat, was observed in almost 70 thousand surgeries 
published and/or presented to date.  
Another advantage of the C/T technique over other alternatives is the ease of adaptation for 
a surgeon who is used to performing classical trabeculectomy. In this surgery, the aim is 
filtration, but not aqueous suppression, and the occurrence of large aqueous outflow by 
several routes including suprachoroidal and posterior chamber yields a huge circulation. As 
it is confirmed by the above comparative studies, obstruction of this passage is less possible 
than other filtrating surgeries. 
The ongoing misfortune of the technique is that it is known and practiced by only a small 
group, and current trend is directed at minimizing trabeculectomy. However, even the 
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publications regarding current strategies against refractory glaucoma cases, clearly 
indicate the necessity for surgical treatment alternatives as effective as C/T. As we 
repetitively stated in our publications and oral, video presentations, C/T has identical 
complications to standard trabeculectomy. In fact, a far more efficient passage is opened 
and most of the anterior chambers do not disappear during operation, and in the post-
operative period, the depth of anterior chamber remains adequate, even in narrow-angle 
eyes. We are positive that once an experienced glaucoma surgeon gets a hold of this 
technique in detail, he/she can use it successfully in indicated cases, yielding satisfactory 
results falling no shorter than other techniques.  
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